Here, we report three new cases with predominant cognitive impairment and associated malignancy, further extending the clinical spectrum associated with ARHGAP26 autoantibodies and strengthening their potential paraneoplastic context. The gene discussed is ARHGAP26; the disease is Cognitive impairment.